Objective: Translation of evidence into practice by health systems can be slow and incomplete and may disproportionately impact disadvantaged populations. Coronary heart disease is the leading cause of death among Aboriginal Australians. Timely access to effective medical care for acute coronary syndrome substantially improves survival. A quality-of-care audit conducted at a regional Western Australian hospital in 2011–2012 compared the Emergency Department management of Aboriginal and non-Aboriginal acute coronary syndrome patients. This audit is used as a case study of translating knowledge processes in order to identify the factors that support equity-oriented knowledge translation. Methods: In-depth interviews were conducted with a purp...
Background Aboriginal Australians have low rates of participation in cardiac rehabilitation (CR), de...
Abstract Background In hospitals globally, patient centred communication is difficult to practice, a...
OBJECTIVES: To assess the effect of a customised, structured cardiovascular disease (CVD) medication...
This abstract was prepared for the inaugural 'HDR Student Conference', Flinders University, November...
To enhance Aboriginal inpatient care and improve outpatient cardiac rehabilitation utilisation, a te...
Objectives: To assess differences in the rates of angiography and subsequent revascularisation for A...
Abstract Objectives: To determine inequities in clinical adherence to national diagnostic and manage...
INTRODUCTION: Cardiovascular disease (CVD) represents a significant burden of disease for Aboriginal...
BACKGROUND: Aboriginal Australians suffer from poorer overall health compared to the general Austral...
Background: The Aboriginal people of Australia have much poorer health and social indicators and a s...
Aboriginal Australians experience high rates of coronary heart disease (CHD) at an early age, highli...
Aboriginal and Torres Strait Islander patients with acute coronary syndromes (ACS) experience lower ...
Introduction Cardiovascular disease (CVD) represents a significant burden of disease for Aboriginal ...
BACKGROUND: Cardiovascular diseases (CVD) are leading causes of mortality and morbidity among Indige...
Like other colonised populations, Indigenous Australians experience poorer health outcomes than non-...
Background Aboriginal Australians have low rates of participation in cardiac rehabilitation (CR), de...
Abstract Background In hospitals globally, patient centred communication is difficult to practice, a...
OBJECTIVES: To assess the effect of a customised, structured cardiovascular disease (CVD) medication...
This abstract was prepared for the inaugural 'HDR Student Conference', Flinders University, November...
To enhance Aboriginal inpatient care and improve outpatient cardiac rehabilitation utilisation, a te...
Objectives: To assess differences in the rates of angiography and subsequent revascularisation for A...
Abstract Objectives: To determine inequities in clinical adherence to national diagnostic and manage...
INTRODUCTION: Cardiovascular disease (CVD) represents a significant burden of disease for Aboriginal...
BACKGROUND: Aboriginal Australians suffer from poorer overall health compared to the general Austral...
Background: The Aboriginal people of Australia have much poorer health and social indicators and a s...
Aboriginal Australians experience high rates of coronary heart disease (CHD) at an early age, highli...
Aboriginal and Torres Strait Islander patients with acute coronary syndromes (ACS) experience lower ...
Introduction Cardiovascular disease (CVD) represents a significant burden of disease for Aboriginal ...
BACKGROUND: Cardiovascular diseases (CVD) are leading causes of mortality and morbidity among Indige...
Like other colonised populations, Indigenous Australians experience poorer health outcomes than non-...
Background Aboriginal Australians have low rates of participation in cardiac rehabilitation (CR), de...
Abstract Background In hospitals globally, patient centred communication is difficult to practice, a...
OBJECTIVES: To assess the effect of a customised, structured cardiovascular disease (CVD) medication...